Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceuticals & Fine Chemicals REACH PRE-REGISTRATION ENDS TODAY: ECHA Opens Back-up System as Applications Top 2 MillionEvonik Sells U.K. Site to ManagementArkema Plans Further Restructuring of its Vinyls BusinessEvonik Rides the Economic Storm with Capacity Increases for Isobutene and MethionineSolvay Signs European Sustainability Charter Related Stories WeylChem Hunts for ‘Sizable’ Deals to Further Increase SalesMerck KGaA Buys Ionic Liquids FirmMylan to Buy Merck KGaA’s Generics Unit for $6.7 BillionWacker Adds to Biologics Capacity in GermanyIndian Firm Buys U.K. Pharma Company

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

October 17, 2007

Mylan Completes Acquisition of Merck’s Generics Business

Chemical Week Editorial Staff

Mylan Laboratories (Canonsburg, PA) has completed the previously announced acquisition of Merck KGaA’s generic drugs business for €4.9 billion ($6.7 billion) in cash. The companies signed a definitive agreement for the deal in May (CW, May 23, p...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers